Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

719
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
719
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

592
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
592
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

979
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
979

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Geospatial analysis reveals similar HIV-1 drug resistance patterns among antiretroviral therapy-experienced children and adolescents (0-17 years) of South Africa.

Communications medicine·2026
Same author

A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis.

The New England journal of medicine·2026
Same author

Preserved Spermatogenesis and Hormonal Function in Men Receiving a Pretomanid Regimen (BPaMZ) for Pulmonary Drug-Resistant Tuberculosis.

Clinical pharmacology and therapeutics·2026
Same author

Role of casual contact in drug-resistant tuberculosis transmission: a molecular epidemiology study.

American journal of respiratory and critical care medicine·2026
Same author

Socio-ecological vulnerability subgroups predict adherence and treatment outcomes in multidrug-resistant tuberculosis and HIV: a latent class analysis.

BMC infectious diseases·2026
Same author

Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trial.

The Lancet. Respiratory medicine·2026
Same journal

Value of the Pitt bacteremia score in predicting the outcome of non-bacteremic patients with infections caused by multidrug-resistant organisms.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same journal

Concurrent comparison of severity of influenza and COVID-19 among hospitalized patients in Hong Kong: a target trial emulation on observational healthcare data.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same journal

Lytic bacteriophages active in urine against multi-drug resistant clinically derived Klebsiella pneumoniae causing urinary tract infection.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same journal

Time to Recovery from Long COVID: A Longitudinal Analysis of Symptom Duration and Risk Factors Using Accelerated Failure Time Models.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same journal

Site matters: extrapulmonary tuberculosis localization patterns and clinical outcomes in the Netherlands,1993-2022.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same journal

When Institutional Transitions Interrupt Prevention: 3HP Tuberculosis Preventive Treatment Continuity in a Paraguayan Prison Cohort.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
See all related articles

Related Experiment Video

Updated: Mar 7, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K

Turning the tide against tuberculosis.

Nesri Padayatchi1, Naressa Naidu1, Gerald Friedland2

  • 1South African Medical Research Council HIV-TB Pathogenesis and Treatment Research Unit, CAPRISA, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Private Bag X7, Congella 4013, South Africa.

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|February 8, 2017
PubMed
Summary
This summary is machine-generated.

Tuberculosis (TB) remains a neglected disease despite its global impact. Scientific advances alone are insufficient to end TB by 2035, necessitating a broader approach beyond conventional biomedical methods.

Keywords:
HIVMDR-TBTuberculosisXDR-TB

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

723

Related Experiment Videos

Last Updated: Mar 7, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

723

Area of Science:

  • Global Health
  • Infectious Diseases
  • Public Health Policy

Background:

  • Tuberculosis (TB) is a persistent global health threat affecting all demographics.
  • The global response to Human Immunodeficiency Virus (HIV) has seen significant progress and prioritization.
  • Nelson Mandela highlighted the disparity in focus between AIDS and TB.

Observation:

  • Despite revolutionary diagnostics and drugs, scientific progress in TB control has been slow.
  • The World Health Organization aims to end TB by 2035, a goal challenged by current strategies.
  • A conventional, myopic biomedical approach dominates TB management and patient care.

Findings:

  • Scientific advances in TB diagnostics and therapeutics are insufficient on their own.
  • The current biomedical approach to TB is inadequate for achieving global elimination goals.
  • Patient care for TB is heavily influenced by a limited, conventional biomedical perspective.

Implications:

  • A paradigm shift beyond purely biomedical interventions is crucial for TB eradication.
  • Increased global attention and resources are needed to combat TB effectively.
  • Integrating broader public health strategies is essential to meet the 2035 TB elimination target.